A Study to Evaluate the Safety and Efficacy of MabThera (Rituximab) in Combination With Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Who Failed on Anti-Tumor Necrosis Factor Alpha Therapy

NCT00468546 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

520

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: MabThera/Rituxan
DRUG: Methotrexate
OTHER: Placebo

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]